DAFTAR PUSTAKA

(1)

51

DAFTAR PUSTAKA

Abu Farha, R., Saleh, A. and AbuRuz, S. (2017) “The impact of drug related problems on health-related quality of life among hypertensive patients in Jordan,” Pharmacy Practice, 15(3), pp. 995–995.

doi:10.18549/PharmPract.2017.03.995.

Altyar, A.E. et al. (2020) “Evaluating Pharmacy Practice in Hospital Settings in Jeddah City, Saudi Arabia: Prescribing and Transcribing—2018,”

Hospital Pharmacy, 55(5), pp. 306–313.

doi:10.1177/0018578719844707.

Barbot, M., Ceccato, F. and Scaroni, C. (2019) “The Pathophysiology and Treatment of Hypertension in Patients With Cushing’s Syndrome,”

Frontiers in Endocrinology, 10. doi:10.3389/fendo.2019.00321.

Barreras, A. and Gurk-Turner, C. (2003) “Angiotensin Ii Receptor Blockers,”

Baylor University Medical Center Proceedings, 16(1), pp. 123–126.

doi:10.1080/08998280.2003.11927893.

Bekele, F. et al. (2021) “Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: Prospective observational study,” SAGE Open Medicine, 9, p. 205031212198962. doi:10.1177/2050312121989625.

Bromfield, S.G. et al. (2017) “Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension,” Hypertension, 70(2), pp. 259–266.

doi:10.1161/HYPERTENSIONAHA.116.09390.

Carey, R.M. et al. (2018) “Prevention and Control of Hypertension,” Journal of the American College of Cardiology, 72(11), pp. 1278–1293.

doi:10.1016/j.jacc.2018.07.008.

Chaturvedi, V.P., Mathur, A.G. and Anand, A.C. (2012) “Rational drug use – As common as common sense?,” Medical Journal Armed Forces India, 68(3), pp. 206–208. doi:10.1016/j.mjafi.2012.04.002.

Choudhry, N.K. et al. (2022) “Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association,”

Hypertension, 79(1). doi:10.1161/HYP.0000000000000203.

Cipolle, R. J., Strand, L. M., & Morley, P. C. (2012). The Care Plan. In Pharmaceutical Care Practice : The Patient-Centered Approach to Medication Management Services (3rd ed.). McGraw Hill Medical.

Cuzzo, B., Padala, S.A. and Lappin, S.L. (2020) “Physiology, Vasopressin,”

StatPearls [Preprint].

Depkes RI. (2009). Undang-Undang Nomor 36 Tahun 2009 tentang Kesehatan. indonesia

(2)

52

Ecobici, M. and Stoicescu, C. (2017) “Arterial Stiffness and Hypertension - Which Comes First?,” Maedica, 12(3), pp. 184–190.

Elliott, W.J. and Ram, C.V.S. (2011) “Calcium Channel Blockers,” The Journal of Clinical Hypertension, 13(9), pp. 687–689.

doi:10.1111/j.1751-7176.2011.00513.x.

Ellis, D. and Miyashita (2011) “Primary hypertension and special aspects of hypertension in older children and adolescents,” Adolescent Health, Medicine and Therapeutics, p. 45. doi:10.2147/AHMT.S11715.

Ellison, D.H. (2019) “Clinical Pharmacology in Diuretic Use,” Clinical Journal of the American Society of Nephrology, 14(8), pp. 1248–1257.

doi:10.2215/CJN.09630818.

Everett, B. and Zajacova, A. (2015) “Gender Differences in Hypertension and Hypertension Awareness Among Young Adults,” Biodemography

and Social Biology, 61(1), pp. 1–17.

doi:10.1080/19485565.2014.929488.

Fares, H. et al. (2016) “Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes.,” Open heart, 3(2), p. e000473. doi:10.1136/openhrt-2016-000473.

Farzam, K. and Jan, A. (2021) “Beta Blockers,” Drugs in Sport, Seventh Edition, pp. 307–315.

Fathnin, F.H., Yuniastuti, A. and Kasmini, O.W. (2020) “The Relation of Drug Amount, Comorbidity, Blood Pressure, and Residential Area to Drug-Related-Problems of Hypertension Patients,” Public Health Perspectives Journal Fildza Huwaina Fathnin, 5(3), pp. 2020–178.

Available at: http://journal.unnes.ac.id/sju/index.php/phpj.

Garin, N. et al. (2021) “Drug related problems in clinical practice: a cross- sectional study on their prevalence, risk factors and associated pharmaceutical interventions,” Scientific Reports, 11(1), p. 883.

doi:10.1038/s41598-020-80560-2.

Guerrero-García, C. and Rubio-Guerra, F. (2018) “Combination therapy in the treatment of hypertension,” Drugs in Context, 7, pp. 1–9.

doi:10.7573/dic.212531.

Guichard, J.L. et al. (2013) “Aldosterone receptor antagonists: current perspectives and therapies,” Vascular Health and Risk Management, 9, pp. 321–331. doi:10.2147/VHRM.S33759.

Harahap, O.H., Badiran, M. and Asriwati (2020) “Analisis Hubungan Peresepan dengan Penggunaan Obat Rasional di Puskesmas Bestari Kecamatan Medan Petisah,” Excellent Midwifery Journal, 3 No.1, pp.

12–25.

Hegde, S. and Aeddula, N.R. (2021) “Secondary Hypertension,” StatPearls [Preprint].

(3)

53

Herman, L.L. et al. (2021) “Angiotensin Converting Enzyme Inhibitors (ACEI).”

Herman, L.L. et al. (2022) Angiotensin Converting Enzyme Inhibitors (ACEI).

Hernandez-Vila, E. (2015) “A Review of the JNC 8 Blood Pressure Guideline,” Texas Heart Institute Journal, 42(3), pp. 226–228.

doi:10.14503/THIJ-15-5067.

Hough, A. et al. (2019) ‘Hypertension’, in J.T. DiPiro et al. (eds) Pharmacotherapy Principles & Practice. McGraw Hill.

Huang, Q. et al. (2019) “A randomized controlled trial on the blood pressure–lowering effect of amlodipine and nifedipine‐GITS in sustained hypertension,” The Journal of Clinical Hypertension, 21(5), pp. 648–657. doi:10.1111/jch.13543.

Iqbal, A.M. and Jamal, S.F. (2021) “Essential Hypertension,” xPharm: The Comprehensive Pharmacology Reference, pp. 1–6.

Juwita, R. et al. (2015) Peran Apoteker dalam Mencegah Drug Related Problems pada Pasien Stroke yang Dirawat Inap, Artikel Penelitian Neurona.

Kementerian Kesehatan RI (2011) “Modul Penggunaan Obat Rasional Dalam Praktek,” Modul Penggunaan Obat Rasional, pp. 3–4.

Kementerian Kesehatan RI (2019) Laporan Nasional Riskesdas 2018, Badan Penelitian dan Pengembangan Kesehatan. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.

Kerr, J.L. (2019) ‘Hypertension’, in S. Sutton (ed.) McGrawHill’s NAPLEX®

Review Guide. McGrawHill.

Khalil, H. and Zeltser, R. (2021) “Antihypertensive Medications,” Southern Medical Journal, 77(5), pp. 621–630.

Kim, H.-J. et al. (2016) “Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension,”

Korean Circulation Journal, 46(3), p. 384.

doi:10.4070/kcj.2016.46.3.384.

MacLaughlin, E.J. and Saseen, J.J. (2020) “Hypertension,” in Dipiro, J.T. et al. (eds) Pharmacotherapy : a Pathophysiology Approach 11th Edition.

11th edn. New York: Mc Graw Hill, pp. 273–359.

Mahmood, S. et al. (2021) “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta- analysis,” International Journal of Clinical Pharmacy, 43(3), pp. 486–

501. doi:10.1007/s11096-021-01236-z.

(4)

54

Mayet, J. and Hughes, A. (2003) “Cardiac and vascular pathophysiology in hypertension,” Heart, 89(9), pp. 1104–1109.

doi:10.1136/heart.89.9.1104.

McEvoy, J.W. et al. (2020) “Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes,” JAMA, 323(4), p. 329.

doi:10.1001/jama.2019.21402.

McKeever, R.G. and Hamilton, R.J. (2022) Calcium Channel Blockers.

Ni, X.-F. et al. (2021) “Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review,” Frontiers in Pharmacology, 12. doi:10.3389/fphar.2021.698907.

Oparil, S. et al. (2018) “Hypertension,” Nature Reviews Disease Primers, 4(1), p. 18014. doi:10.1038/nrdp.2018.14.

Parker, J.D. et al. (2020) “Comparison of short-acting versus extended- release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease,” Scientific Reports, 10(1), p. 565. doi:10.1038/s41598-019-56890-1.

Princewel, F. et al. (2019) “Prevalence and risk factors associated with hypertension among adults in a rural setting: the case of Ombe, Cameroon,” Pan African Medical Journal, 34.

doi:10.11604/pamj.2019.34.147.17518.

Rodziewicz, T.L., Houseman, B. and Hipskind, J.E. (2021) Medical Error Reduction and Prevention, StatPearls.

Sabbatini, A.R. and Kararigas, G. (2020) “Estrogen-related mechanisms in sex differences of hypertension and target organ damage,” Biology of Sex Differences, 11(1), p. 31. doi:10.1186/s13293-020-00306-7.

Sanii, Y. et al. (2016) “Role of pharmacist counseling in pharmacotherapy quality improvement,” Journal of Research in Pharmacy Practice, 5(2), p. 132. doi:10.4103/2279-042X.179580.

Shrout, T., Rudy, D.W. and Piascik, M.T. (2017) “Hypertension update, JNC8 and beyond,” Current Opinion in Pharmacology, 33, pp. 41–46.

doi:10.1016/j.coph.2017.03.004.

Shukuri, A., Tewelde, T. and Shaweno, T. (2019) “Prevalence of old age hypertension and associated factors among older adults in rural Ethiopia,” Integrated Blood Pressure Control, Volume 12, pp. 23–31.

doi:10.2147/IBPC.S212821.

Smith, D.K., Lennon, R.P. and Carlsgaard, P.B. (2020) “Managing Hypertension Using Combination Therapy.,” American family physician, 101(6), pp. 341–349.

(5)

55

Song, J.-J. et al. (2020) “Gender Differences in Hypertension,” Journal of Cardiovascular Translational Research, 13(1), pp. 47–54.

doi:10.1007/s12265-019-09888-z.

Tan, J.L. and Thakur, K. (2021) “Systolic Hypertension,” StatPearls [Preprint].

Tariq, R.A. et al. (2021) “Medication Dispensing Errors And Prevention,”

StatPearls [Preprint].

Tuloli, T.S., Pakaya, M.S. and Pratiwi, S.D. (2021) “Identifikasi Drug Related Problems (DRPs) Pasien Hipertensi di RS Multazam Kota Gorontalo,”

Indonesian Journal of Pharmaceutical Education (e-Journal), 1(1), pp.

2775–3670. doi:10.22487/.ijpe.vlil.9945.

Wang, J. et al. (2020) “Mask use during COVID-19: A risk adjusted strategy,” Environmental Pollution, 266(January), p. 115099.

doi:10.1016/j.envpol.2020.115099.

Weeda, E.R. et al. (2016) “Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta- regression analysis,” International Journal of Cardiology, 216, pp.

104–109. doi:10.1016/j.ijcard.2016.04.082.

WHO (2021) Hypertension. Available at: https://www.who.int/health- topics/hypertension#tab=tab_1 (Accessed: September 11, 2021).

Woodford, H.J. (2020) “Calcium Channel Blockers Co-prescribed with Loop Diuretics: A Potential Marker of Poor Prescribing?,” Drugs & Aging, 37(2), pp. 77–81. doi:10.1007/s40266-019-00730-4.

Xanthakis, V. and Vasan, R.S. (2013) “Aldosterone and the Risk of Hypertension,” Current Hypertension Reports, 15(2), pp. 102–107.

doi:10.1007/s11906-013-0330-y.

Zhou, S. et al. (2018) “Analyzing Medication Error Reports in Clinical Settings: An Automated Pipeline Approach.,” AMIA ... Annual Symposium proceedings. AMIA Symposium, 2018, pp. 1611–1620.

(6)

56 Lampiran 1. Surat Izin Penelitian

(7)

57 Lampiran 2. Sertifikat Ethical clearance

(8)

58 Lampiran 3. Lembar Hasil Penelitian

No Inisi al

J K

Usi a

Riwayat penyaki

t lain

Riwayat penggunaan obat (bulan sebelumnya)

Tgl Periksa TD Nama obat R/ pill

count

Penyebab DRPS

Nama obat dosis

Keluha

n Indikas

i tanpa obat

Obat tanpa indikas

i

Obat salah

Dosis obat kurang

Reaksi obat merugika

n

Dosis obat lebih

kepatuha n

1 M

L 64 Amlodipin 5

mg 1x1 10/04/21 160/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 21/4/2021 150/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 25/5/2021 140/90 Amlodipin 5 mg 100

Amlodipin 10

mg 1x1 03/06/21 160/190 Amlodipin 10

mg X X X X X

Amlodipin 5

mg 1x1 03/08/21 230/130 Amlodipin 10

mg Amlodipin 5

mg 1x1 31/08/21 136/84 Amlodipin 5 mg OK6

2 DB

P Amlodipin 5

mg 1x1 04/05/21 160/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 04/06/21 150/80

Amlodipin 5 mg, Allopurinol,

Vitamin B6 Asam

urat

Amlodipin 5 mg, Allopurinol, Vitamin B6

1x1 02/07/21 160/80 Amlodipin 5

mg, Allopurinol 100 X X X X X

Asam urat

Amlodipin 5

mg, Allopurinol 1x1 03/08/21 160/80 Amlodipin 5 mg

Amlodipin 5

mg 1x1 30/8/2021 154/86

Amlodipin 5 mg, Allopurinol,

Simvastatin

OK6

3 HS

P Amlodipin 5

mg 1x1 07/05/21 150/100

Amlodipin 5 mg, Ibuprofen,

Vitamin B1

31/08/21 140/90 Amlodipin 5 mg

Amlodipin 5 mg, Omeprazole,

100 X X X X X X

(9)

59

Antasida, Na.

Diclofenac, GG Amlodipin 5

mg, Omeprazol,

Antasida

4 ML

L 45 01/03/19 190/130 Amlodipin 10

mg, Amlodipin 10

mg, 1x1 15/3/2021 180/120 Amlodipin 10

mg, Furosemid Amlodipin 10

mg, Furosemid 1x1 31/8/2021 280/130 Amlodipin 10

mg OK7

5 MS P 61 20/01/2017 150/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 12/05/18 180/80 Amlodipin 5 mg X X X X X X

Amlodipin 5

mg 1x1 09/01/21 190/90 Amlodipin 5 mg 75 KP1

6 TT

P 68 Amlodipin 5

mg 1x1 16/3/2020 140/80 Amlodipin 5 mg

Amlodipin 5

mg 1x1 25/07/20 140/70 Amlodipin 5 mg

Amlodipin 5

mg 1x1 01/07/21 160/90 Amlodipin 5 mg 100 X X X X X X

Amlodipin 5

mg 1x1 31/7/2021 Amlodipin 10

mg

7 HP P 52 09/04/17 160/110 Amlodipin 5 mg

Amlodipin 5

mg 1x1 23/05/17 140/90 Amlodipin 5 mg 100

Amlodipin 5

8 S L 55 20/2/2017 140/100 Nifedipin

Nifedipin 1x1 23/5/2017 150/100 Nifedipin 100

Nifedipin 1x1 04/08/20 200/120 Nifedipin 10 mg OS2

9 AL

P 71 Amlodipin 5

mg 1x1 31/8/2020 140/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 02/10/20 130/90 Amlodipin 5 mg 75

Amlodipin 5

mg 1x1 22/12/2020 120/80 Amlodipin 5 mg

(10)

60

Amlodipin 5

mg 1x1 29/2/2021 130/90 Amlodipin 5 mg KP1

10 ML L 61 Amlodipin 5

mg 13/9/2021 160/80 Amlodipin 5 mg 100 X X X X X X

11 PB L 25/1/2019 160/100 Amlodipin 5 mg

Amlodipin 5

mg 1x1 06/02/19 140/100 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 19/2/2019 130/90

12 E

P 70 Amlodipin 5

mg 1x1 07/03/20 180/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 09/06/21 170/80 Amlodipin 5 mg 100

Amlodipin 5

13 TS

P Amlodipin 5

mg 1x1 31/1/2020 150/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 26/3/2020 140/90 Amlodipin 5 mg 80

Amlodipin 5

mg 1x1 08/04/21 160/90 Amlodipin 5 mg KP1

14 M P 08/02/21 160/100 Amlodipin 5 mg 100

15 HS

P 54 Amlodipin 5

mg 1x1 02/05/21 150/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 03/05/21 110/60 Amlodipin 5 mg

Amlodipin 5

mg 1x1 04/05/21 200/100 Amlodipin 5 mg

Amlodipin 5

mg 1x1 28/5/2021 140/80 Amlodipin 10

mg 100

Amlodipin 10

16 JS

L 66 Amlodipin 5

mg 1x1 31/1/2019 120/20 Amlodipin 5 mg

17 MR

P Amlodipin 5

Amlodipin 5

mg 1x1 03/07/21 200/100 Amlodipin 10

mg 100

Amlodipin 10

mg 1x1 31/7/2021 160/100 Amlodipin 5 mg

(11)

61

Amlodipin 5

mg 1x1 20/8/2021 170/100 Amlodipin 5 mg

18 JTL L 57 Amlodipin 5

mg 1x1 21/12/2020 140/80 Amlodipin 5 mg

Amlodipin 5

mg 1x1 23/6/21 140/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 28/8/2021 140/90 Amlodipin 5 mg

19 YRL

P 68 Amlodipin 5

mg 1x1 08/10/17 140/100 Nifedipin

Nifedipin 1x1 13/11/2017 140/100 Amlodipin

20 YRT

P 51 Amlodipin 5

mg 1x1 08/06/21 170/110 Amlodipin 5 mg 75 KP1

21 AR L 51 Amlodipin 1x1 08/09/21 140/77 Livron 100

22 AK P 67 08/06/21 200/100 Amlodipin 5 mg 100 OS2

23 L

L 72

Amlodipin 5 mg, ciprofloxacin

1x1 15/7/2020 130/70 Amlodipin 5 mg 100

24 PP P 78 Amlodipin 5

mg 1x1 26/08/21 170/70 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 28/08/21 160/80 Amlodipin 5 mg

25 AK P 59 Nifedipin 1x1 04/04/20 150/80 Amlodipin 5 mg

Amlodipin 5

mg 1x1 19/7/2021 140/80 Amlodipin 5 mg 100

Amlodipin 5

26 YL L 52 Amlodipin 10

mg 1x1 23/06/21 160/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 17/5/2021 160/100 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 08/02/21 130/90 Amlodipin 5 mg

27 LM

L 63 Amlodipin 5

mg 1x1 08/06/21 180/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 08/12/21 150/90 Amlodipin 5 mg

28 WS

L 75 Amlodipin 5

mg 1x1 13/1/2021 160/90 Amlodipin 5 mg

(12)

62

Amlodipin 5

mg 1x1 22/6/2021 180/110 Amlodipin 5 mg

Amlodipin 5

mg 1x1 21/7/2021 140/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 20/8/2021 130/80 Amlodipin 5 mg

29 PS

L 76 Amlodipin 5

mg 1x1 23/5/2018 130/90 Amlodipin 5 mg 100

30 P

L Amlodipin 100

mg 1x1 18/8/2020 170/70 Amlodipin 10

mg Amlodipin 10

mg 1x1 21/1/2021 203/83 Amlodipin 10

mg 100

Amlodipin 10

mg 1x1 11/02/21 180/90 Amlodipin 10

mg Amlodipin 10

mg 1x1 15/7/2021 160/70 Amlodipin 10

mg

31 JP L 79 Captopril 1x1 29/11/2014 150/100 Captopril

Captopril 1x1 10/12/14 150/100 Amlodipin 100

Amlodipin 1x1 19/12/2014 120/110 Amlodipin

32 PP

L 42 Amlodipin 5

mg 1x1 26/11/2020 138/90 Amlodipin 5 mg 100

33 R L 31 Nifedipin 1x1 15/5/2021 150/90 Nifedipin

Nifedipin 1x1 14/6/2021 150/100 Nifedipin 100

Nifedipin 1x1 14/7/2021 150/100 Nifedipin OK1

34 MPP

P 53 Amlodipin 5

mg 1x1 28/5/2021 120/80 amlodipin 5 mg

Amlodipin 5

mg 1x1 16/7/2021 120/80 amlodipin 5 mg 100

35 AD

P 44 Amlodipin 5

mg 1x1 08/10/21 190/130 Amlodipin 5 mg 100

36 HR L 65 Amlodipin 1x1 25/3/2021 170/90 Amlodipin

Amlodipin 1x1 24/4/2021 139/95 Amlodipin 100

37 BL

L 78 Amlodipin 5

mg 1x1 20/8/2021 140/83 Amlodipin 5 mg 100

38 S P 58 08/06/21 190/110 Amlodipin 5 mg 100 OK1

39 L P 61 Nifedipin 1x1 12/03/21 140/60 Nifedipin

(13)

63

Nifedipin 1x1 27/4/2021 160/90 Amlodipin 100 OK7

40 BL

L 68 Amlodipin 5

mg 1x1 28/12/2020 136/87 Amlodipin 5 mg

Amlodipin 5

mg 1x1 25/2/2021 130/80 Amlodipin 10

mg 100

41 DL P 56 08/07/21 200/110 Amlodipin 5 mg 100 OK6

42 MB

P 73 Amlodipin 5

mg 1x1 03/11/21 150/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 31/5/2021 160/100 Amlodipin 5 mg

Amlodipin 5

mg 1x1 26/6/2021 120/70 Amlodipin 5 mg

43 DT

L 51 Amlodipin 5

mg 1x1 17/6/2021 130/90 Amlodipin 5 mg 100

44 PP

P 51 Asam

urat

Amlodipin 10

mg 1x1 20/8/2021 120/90 Amlodipin 10

mg, Allopurinol 100

45 AP

L Amlodipin 10

mg 1x1 06/11/21 180/110 Amlodipin 10

mg 100

Amlodipin 5

mg 1x1 Amlodipin 5 mg

46 DP

L 62 Amlodipin 1o

mg 1x1 17/5/2021 200/110 Amlodipin 10

mg Amlodipin 10

mg 1x1 12/06/21 170/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 02/07/21 110/100 Amlodipin 5 mg

47 BL

P 53 Amlodipin 5

mg 1x1 22/4/2021 180/100 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 09/06/21 170/90 Amlodipin 10

mg

48 S L 81 Amlodipin 5

mg 1x1 19/6/2021 160/70 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 Amlodipin 5 mg

49 L

L Amlodipin 5

mg 1x1 30/6/2021 120/70 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 05/08/21 110/70 Amlodipin 5 mg

50 LL P 47 Amlodipin 5

mg 1x1 13/12/2019 130/80 Amlodipin

(14)

64

Amlodipin 5

mg 1x1 15/06/20 150/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 05/10/20 150/90 Amlodipin 5 mg

Amlodipin 5

mg 1x1 06/11/20 140/90 Amlodipin 5 mg

51 YT

L 69 Amlodipin 5

mg, Furosemid 1x1 (1-0- 0)

24/6/2021 160/100 Amlodipin,

Furosemid 100

03/07/21 160/90 Amlodipin,

Furosemid

52 YT L 71 Amlodipin 5

mg 24/6/2021 140/90 Amlodipin 5 mg 100

Amlodipin 5

mg 1x1 25/8/2021 140/90 Amlodipin 5 mg